€30m investment at Boston Scientific

€30 million is to be invested in Boston Scientific’s Cork facility, the company announced yesterday.

This research, development, and innovation investment, which is supported by the Irish Government through IDA Ireland, will further diversify the range of technologies developed and manufactured at the Boston Scientific Cork site.

It is expected to generate more than 70 new quality, engineering and production jobs over the next three years.

It said the investment would accelerate the development and manufacturing of minimally invasive medical technologies that treat patients suffering from cancer and peripheral arterial diseases around the world.

Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar said: “This investment will allow the company to grow and develop its world leading technologies and ensure that it continues helping to improve and save lives.”

IDA Ireland is tasked with attracting investment into Ireland by foreign-owned companies with a focus on jobs growth and industrial transformation in high growth sectors including MedTech.

Martin Shanahan, CEO, IDA Ireland, said: “Boston Scientific has had a strong presence in the Cork business community for nearly 25 years.

“As the company grows and expands into more therapeutic areas through internal RD&I and acquisitions, its continued investment in ongoing operations and highly skilled local talent is encouraging.

“This expansion is further evidence of the southwest region’s thriving medtech cluster.”

Sean Gayer, Vice President Operations at Boston Scientific Cork, said: “We are delighted to be adding new quality, engineering and production capabilities to our Cork facility and contributing further to the strong medtech sector in the region.”